Pfizer CEO sees annual COVID vaccine rather than frequent boosters

Summary by Ground News

Pfizer/BioNtech's COVID-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant. With cases soaring, some countries have expanded vaccine booster programmes. Pfizer could be ready to file for approval for a redesigned vaccine, and mass produce it, as soon as March.

4 months ago

News Articles

Reuters

Pfizer CEO sees annual COVID vaccine rather than frequent boosters

JERUSALEM - Pfizer Inc Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic. Pfizer/BioNtech's COVID-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant but less effective in preventing transmission. With cases

4 months ago·United Kingdom

Read Full Article